Adaptilens Founder and CEO, Liane Clamen, was the guest speaker at Randolph Cohen's Entrepreneurship course at Harvard Business School yesterday.
关于我们
Our mission at Adaptilens is to restore youthful vision by imitating the natural lens of the young, healthy eye. The Adaptilens accommodating intraocular lens (A-IOL) recaptures the eye's intrinsic ability to accommodate by responding to its natural signal to focus, allowing for clear vision over a range of distances without the need for glasses.
- 网站
-
https://adaptilens.com/
Adaptilens的外部链接
- 所属行业
- 生物技术
- 规模
- 2-10 人
- 总部
- Newton，MA
- 类型
- 私人持股
- 领域
- IOL和A-IOL
地点
-
主要
获取路线
US，MA，Newton，02467
Adaptilens员工
-
Daniel Stanley
COO at Adaptilens | Medical Device R&D SME
-
Brett Thomes, Ph.D.
Medical device R&D and manufacturing leader with expertise in driving innovation, streamlining development/transfer, and optimizing…
-
Jayanth Batchu
Associate/EIR at Xontogeny & Founder at Startup in Stealth-mode (Biotech)
-
Liane Clamen
Founder and CEO. Adaptilens, Inc.
动态
-
Adaptilens' Founder and CEO Liane Clamen discussed her entrepreneurial journey at the Founder's Journey Fireside Chat during Harvard Grid's Launching Tech Ventures event.
Another successful tech translation workshop in the books! From discussions on building the right team, to case studies on how to learn from past failures - students were buzzing with ideas, enthusiasm, and questions that made the day meaningful and impactful. Special thanks to our Harvard Business School faculty that led the day - Thomas Eisenmann, Jim Matheson, Tom Clay, and Joshua Krieger and to Liane Clamen - founder and CEO of Adaptilens who shared insights on how to face and overcome challenges in the startup journey. #Harvardinnovation #Harvardventuring #Toughtech
-
Adaptilens' CEO, Liane Clamen, joined an esteemed panel of CEOs to lead the MedTech CEO-Only Forum at #JPM25, hosted by Giovanni Lauricella, CEO of Lifeblood and Martin Gomez, Partner at Goodwin.
-
-
Adaptilens转发了
As we reflect on 2024, we're proud to spotlight over 130 remarkable achievements from our entrepreneurial community, driving innovation and impact across industries: ? Adaptilens is developing an intraocular lens that responds to the eye's natural signal to focus, eliminating the need for eyeglasses or contact lenses. This year, the company raised $17.5 million in funding. ? Akouos, a biotech company focused on restoring hearing in deaf children, was featured in The New York Times for helping a child hear for the first time. ? IAMBIC is disrupting the centuries-old footwear industry with their sizeless, precision-fit footwear driven by proprietary AI algorithms. In 2024, IAMBIC completed Techstars NYC, secured $1.25 million in non-dilutive federal and state funding, and expanded the team with seven key hires. Explore more inspiring accomplishments: https://lnkd.in/duWGZ5Kt
-
-
Adaptilens was well represented at the Ophthalmology Innovation Source XIV in San Diego where our CEO Liane Clamen spoke on the panel "Future of Anterior Innovation: A Panel of Disruptors and Visionaries." Thank you Anthony Wallace - Bausch + Lomb Surgical for inviting our CEO and facilitating an inspiring discussion.
-
-
Adaptilens is excited to share Rowan Walrath's well-researched and insightful article in C&EN showcasing successful founder-led biotech companies like Adaptilens. We appreciate Rowan's recognition of Adaptilens's Founder and CEO Liane Clamen and Rowan's spotlight on champions of the founder-led movement like Chris Garabedian, Gianna Hoffman-Luca, and their team at Xontogeny and Perceptive Advisors, as well as Tony Kulesa and the Pillar VC team.
Scientists who want to start and lead companies are often met with skepticism, and first-time founders get it the worst.
-
We’re excited to share that Adaptilens has been nominated for the Emerging MedTech Company of the Year at the 12th Annual #NEVYs24! Thank you to the New England Venture Capital Association (NEVCA) for this nomination. We are honored to be recognized with the other companies and breakthroughs of New England that are reshaping industries and driving the innovation economy forward. Read the full announcement here: https://lnkd.in/e548JKAk #NEVYsSurvivor #NEVCA #Innovation
-
-
Adaptilens is pleased to announce that our CEO, Dr. Liane Clamen, was invited to participate in a panel discussion on the "Future of Anterior Innovation" at the Ophthalmology Innovation Summit next month.
We’re excited to have Dr. Liane Clamen, Founder & CEO of Adaptilens, as a speaker at OIS XIV! As an experienced leader in ophthalmic innovation, Dr. Clamen will be sharing her invaluable insights on the "Future of Anterior Innovation" panel this November. Don’t miss out—secure your spot for OIS XIV today! https://lnkd.in/eMd2jAJc #OIS #OISXIV #Ophthalmology #OphthalmologyInnovation #Innovation #Anterior #LianeClamen #Adaptilens
-
-
Adaptilens转发了
It was a privilege to present Adaptilens at the International Society of Presbyopia Conference in Barcelona. I enjoyed connecting with leaders and innovators in the field.
-
-
Our CEO, Dr. Liane Clamen, was honored to be invited to the AECOS (American-European Congress of Ophthalmic Surgery) Innovation Forum in Deer Valley, Utah. She shared an Adaptilens update with leading ophthalmologists and pioneers in the field.
-